SHR-1701 Combined With Fluzoparib in Lung Squamous Cell Carcinoma

Clinical trial NCT04937972 · UNKNOWN

Trial details

NCT number: NCT04937972
Sponsor: Hunan Province Tumor Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2021-07-01
Primary completion: 2024-12-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.